Literature DB >> 2676956

Rabbit hindlimb glucose uptake assessed with positron-emitting fluorodeoxyglucose.

K A Mossberg1, R W Rowe, T J Tewson, H Taegtmeyer.   

Abstract

The feasibility of estimating skeletal muscle glucose uptake in vivo was examined by using the glucose analogue 2-[18F]deoxy-2-fluoro-D-glucose (2-[18F]FDG) in the rabbit hindlimb. A pair of collimated coincidence gamma photon detectors was used to monitor the accumulation of tracer in the tissue after 2-[18F]FDG injection. Time-activity curves were generated on a second-by-second basis under control conditions, during increased contractile activity, or hyperinsulinemia. The arterial input of 2-[18F]FDG, plasma glucose, lactate, free fatty acids, and insulin were determined. A graphical (Patlak plot) procedure was used to determine the fractional rate of tracer phosphorylation and therefore trapping in the muscle. From the graphical analysis, the estimated rate of glucose phosphorylation (R) in the unperturbed state was calculated to be 0.037 mumol.min-1.ml-1 of tissue. During perturbation by electrical stimulation, an increase in the rate of tracer phosphorylation (K) was observed. No change in the rate of tracer phosphorylation was observed during hyperinsulinemia. The results support the use of 2-[18F]FDG and the graphical procedure for the noninvasive assessment of glucose uptake by skeletal muscle in vivo. The method described is sensitive to changes in the rate of tracer uptake with respect to time and physiological interventions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676956     DOI: 10.1152/jappl.1989.67.4.1569

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

Authors:  P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 2.  Total-Body PET Imaging of Musculoskeletal Disorders.

Authors:  Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi
Journal:  PET Clin       Date:  2021-01

3.  Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.

Authors:  P Nuutila; M J Knuuti; O J Heinonen; U Ruotsalainen; M Teräs; J Bergman; O Solin; H Yki-Järvinen; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography.

Authors:  R C Eastman; R E Carson; D G Orloff; C S Cochran; J F Perdue; M M Rechler; F Lanau; C T Roberts; J Shapiro; J Roth
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Insulin action on heart and skeletal muscle glucose uptake in essential hypertension.

Authors:  P Nuutila; M Mäki; H Laine; M J Knuuti; U Ruotsalainen; M Luotolahti; M Haaparanta; O Solin; A Jula; V A Koivisto
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.